ParrasLab's profile picture.

Carlos.Parras.Team

@ParrasLab

Carlos.Parras.Team reposted

Our latest paper out by @merbengochea @TheHassanLab about the numerical cognitive abilities of flies and the first evidence for the neurons required for this capacity in the visual system


French glial cell happy hour in Berlin ,🙃

ParrasLab's tweet image. French glial cell happy hour in Berlin ,🙃
ParrasLab's tweet image. French glial cell happy hour in Berlin ,🙃

Carlos.Parras.Team reposted

Et si la maladie d’#Alzheimer imprimait sa marque chez l’embryon ? Des scientifiques de l’@InstitutCerveau (@inserm), montrent que la protéine précurseur de l’amyloïde (APP) possède un rôle biologique spécifique lors du neurodéveloppement. institutducerveau-icm.org/fr/actualite/a…


Carlos.Parras.Team reposted

@ShabaniDania @TheHassanLab @InstitutCerveau @ParisBrainInst paper on how the APP protein-famous for its role in Alzheimer’s disease- is actually a regulator of the tempo of human cortical development is now out in @ScienceAdvances science.org/doi/10.1126/sc…


Carlos.Parras.Team reposted

June 20th in Paris: 'The Times of Embryonic Development’ A symposium at Collège de France @cdf1530. Open, no registration, super speakers 👇🏼@PourquieO @DesplanLab @briscoejames @EbisuyaMiki @VanderhaeghenP2 @maitrejl @Anissakempf @gregorscience @the_Node @LecuitLab

Duboule's tweet image. June 20th in Paris: 'The Times of Embryonic Development’ A symposium at Collège de France @cdf1530. Open, no registration, super speakers 👇🏼@PourquieO @DesplanLab @briscoejames @EbisuyaMiki @VanderhaeghenP2 @maitrejl @Anissakempf @gregorscience @the_Node @LecuitLab

Carlos.Parras.Team reposted

braincouncil.eu/pledge-for-sci… European Parliament is about to discuss a complete ban for animal research. This is real and will be catastrophic for progress in the fight against many diseases. Please support @EU_Brain pledge:


Carlos.Parras.Team reposted

My thoughts on the phase 3 results of Alzheimer's drug lecanemab from Biogen and Eisai, presented at #CTAD #CTAD22 and published this evening in the @NEJM. Major takeaway – this is NOT the breakthrough we have been waiting for. Key points:

schrag_matthew's tweet image. My thoughts on the phase 3 results of Alzheimer's drug lecanemab from Biogen and Eisai, presented at #CTAD #CTAD22 and published this evening in the @NEJM. Major takeaway – this is NOT the breakthrough we have been waiting for. Key points:

I am delighted to tell you that our paper on Tensin3 is now available as html version in eLife doi.org/10.7554/eLife.…, with a great layout and lots of shared data files. Thanks a lot to all the people involved! particularly to @EmericMerour and @TheHassanLab at @ParisBrainInst

ParrasLab's tweet image. I am delighted to tell you that our paper on Tensin3 is now available as html version in eLife doi.org/10.7554/eLife.…, with a great layout and lots of shared data files. Thanks a lot to all the people involved! particularly to @EmericMerour and @TheHassanLab at @ParisBrainInst

I am glad to share with you our last study on Tensin3 and oligodendrocyte differentiation summarizing 8 years of work by @EmericMerour & Hatem Hmidan and collaborators at the @ParisBrainInst biorxiv.org/content/10.110….



As promised @GordonConf#Myelin here is the revised version after Review Commons peer-review of our Tns3 paper, that has been submitted now to eLife. I hope you will appreciate the improvements.  biorxiv.org/content/10.110…


Loading...

Something went wrong.


Something went wrong.